Model Medicines partnered with LEO Pharma to accelerate drug discovery

Press
Written By Lani Nguyen

Model Medicines, of San Diego, and Leo Pharma A/S, of Ballerup, Denmark, agreed to discover and validate drugs for treating inflammatory skin diseases. The Model Medicines platform is designed to reduce the amount of time it takes to bring a drug to market. Leo specializes in dermatological therapies.

This article originally appeared on Bioworld, prior to the rebrand of Repurpose.AI to Model Medicines, read the full article here.

Lani Nguyen
Previous

Model Medicines partnered with LEO Pharma to accelerate drug discovery
Next

AI drug discovery startup strikes partnership with LEO Pharma